These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 16876451)

  • 1. Metabolic control during exercise with and without medium-chain triglycerides (MCT) in children with long-chain 3-hydroxy acyl-CoA dehydrogenase (LCHAD) or trifunctional protein (TFP) deficiency.
    Gillingham MB; Scott B; Elliott D; Harding CO
    Mol Genet Metab; 2006; 89(1-2):58-63. PubMed ID: 16876451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of higher dietary protein intake on energy balance and metabolic control in children with long-chain 3-hydroxy acyl-CoA dehydrogenase (LCHAD) or trifunctional protein (TFP) deficiency.
    Gillingham MB; Purnell JQ; Jordan J; Stadler D; Haqq AM; Harding CO
    Mol Genet Metab; 2007 Jan; 90(1):64-9. PubMed ID: 16996288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal dietary therapy of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency.
    Gillingham MB; Connor WE; Matern D; Rinaldo P; Burlingame T; Meeuws K; Harding CO
    Mol Genet Metab; 2003 Jun; 79(2):114-23. PubMed ID: 12809642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accumulation of 3-hydroxy-fatty acids in the culture medium of long-chain L-3-hydroxyacyl CoA dehydrogenase (LCHAD) and mitochondrial trifunctional protein-deficient skin fibroblasts: implications for medium chain triglyceride dietary treatment of LCHAD deficiency.
    Jones PM; Butt Y; Bennett MJ
    Pediatr Res; 2003 May; 53(5):783-7. PubMed ID: 12621125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of optimal dietary therapy upon visual function in children with long-chain 3-hydroxyacyl CoA dehydrogenase and trifunctional protein deficiency.
    Gillingham MB; Weleber RG; Neuringer M; Connor WE; Mills M; van Calcar S; Ver Hoeve J; Wolff J; Harding CO
    Mol Genet Metab; 2005; 86(1-2):124-33. PubMed ID: 16040264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The safety of Lipistart, a medium-chain triglyceride based formula, in the dietary treatment of long-chain fatty acid disorders: a phase I study.
    MacDonald A; Webster R; Whitlock M; Gerrard A; Daly A; Preece MA; Evans S; Ashmore C; Chakrapani A; Vijay S; Santra S
    J Pediatr Endocrinol Metab; 2018 Mar; 31(3):297-304. PubMed ID: 29425111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated hydroxyacylcarnitines in a carrier of LCHAD deficiency during acute liver disease of pregnancy - a common feature of the pregnancy complication?
    Eskelin PM; Laitinen KA; Tyni TA
    Mol Genet Metab; 2010 Jun; 100(2):204-6. PubMed ID: 20363656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of fasting, feeding and exercise on plasma acylcarnitines among subjects with CPT2D, VLCADD and LCHADD/TFPD.
    Elizondo G; Matern D; Vockley J; Harding CO; Gillingham MB
    Mol Genet Metab; 2020; 131(1-2):90-97. PubMed ID: 32928639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased and early lipolysis in children with long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency during fast.
    Haglind CB; Nordenström A; Ask S; von Döbeln U; Gustafsson J; Stenlid MH
    J Inherit Metab Dis; 2015 Mar; 38(2):315-22. PubMed ID: 25141826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of mitochondrial trifunctional protein deficiency in a blood spot from the newborn screening card by tandem mass spectrometry and DNA analysis.
    Matern D; Strauss AW; Hillman SL; Mayatepek E; Millington DS; Trefz FK
    Pediatr Res; 1999 Jul; 46(1):45-9. PubMed ID: 10400133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of bezafibrate in two patients with mitochondrial trifunctional protein deficiency.
    Suyama T; Shimura M; Fushimi T; Kuranobu N; Ichimoto K; Matsunaga A; Takayanagi M; Murayama K
    Mol Genet Metab Rep; 2020 Sep; 24():100610. PubMed ID: 32509533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substrate oxidation and cardiac performance during exercise in disorders of long chain fatty acid oxidation.
    Behrend AM; Harding CO; Shoemaker JD; Matern D; Sahn DJ; Elliot DL; Gillingham MB
    Mol Genet Metab; 2012 Jan; 105(1):110-5. PubMed ID: 22030098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-chain fatty acid oxidation during early human development.
    Oey NA; den Boer ME; Wijburg FA; Vekemans M; Augé J; Steiner C; Wanders RJ; Waterham HR; Ruiter JP; Attié-Bitach T
    Pediatr Res; 2005 Jun; 57(6):755-9. PubMed ID: 15845636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molecular basis of pediatric long chain 3-hydroxyacyl-CoA dehydrogenase deficiency associated with maternal acute fatty liver of pregnancy.
    Sims HF; Brackett JC; Powell CK; Treem WR; Hale DE; Bennett MJ; Gibson B; Shapiro S; Strauss AW
    Proc Natl Acad Sci U S A; 1995 Jan; 92(3):841-5. PubMed ID: 7846063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variability in the clinical management of fatty acid oxidation disorders: results of a survey of Canadian metabolic physicians.
    Potter BK; Little J; Chakraborty P; Kronick JB; Evans J; Frei J; Sutherland SC; Wilson K; Wilson BJ
    J Inherit Metab Dis; 2012 Jan; 35(1):115-23. PubMed ID: 21630065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What is the role of medium-chain triglycerides in the management of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency?
    Lund AM; Dixon MA; Vreken P; Leonard JV; Morris AA
    J Inherit Metab Dis; 2003; 26(4):353-60. PubMed ID: 12971423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis, Treatment, and Clinical Outcome of Patients with Mitochondrial Trifunctional Protein/Long-Chain 3-Hydroxy Acyl-CoA Dehydrogenase Deficiency.
    De Biase I; Viau KS; Liu A; Yuzyuk T; Botto LD; Pasquali M; Longo N
    JIMD Rep; 2017; 31():63-71. PubMed ID: 27117294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical, clinical and molecular findings in LCHAD and general mitochondrial trifunctional protein deficiency.
    Olpin SE; Clark S; Andresen BS; Bischoff C; Olsen RK; Gregersen N; Chakrapani A; Downing M; Manning NJ; Sharrard M; Bonham JR; Muntoni F; Turnbull DN; Pourfarzam M
    J Inherit Metab Dis; 2005; 28(4):533-44. PubMed ID: 15902556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-exercise medium-chain triglyceride application prevents acylcarnitine accumulation in skeletal muscle from very-long-chain acyl-CoA-dehydrogenase-deficient mice.
    Primassin S; Tucci S; Herebian D; Seibt A; Hoffmann L; ter Veld F; Spiekerkoetter U
    J Inherit Metab Dis; 2010 Jun; 33(3):237-46. PubMed ID: 20446112
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.